conmed.com (CNMD) - Market Cap to Net Assets Ratio

CONMED Corp - graphic logo of issuer CNMD

The financial stability of CONMED Corporation (CNMD) depends on government clinic contracts and the stability of component logistics, with the current indicator standing at 1.32. The brand's competitive advantage is based on exclusive developments in endoscopy and physician loyalty to the systems' interface. The price history on GURU.Markets demonstrates the impact of US government budget limits on the sales of expensive specialized instrumentation.

CONMED Inc. (CNMD) - Market Value to Book Value from 07/04/2022 to 10/29/2026
Manufactured product of CONMED Corp

The ratio of market value to net assets determines the premium the market is willing to pay for every dollar of the company's equity. By analyzing the price-to-book value trend, an investor assesses the capitalization efficiency of CONMED Corporation (CNMD) high-precision engineering developments in bloodless surgery, where a steady ratio confirms the high market value of its intellectual property and innovative medical technologies.

Competing companies

DXCM: Market Capitalization to Book Value Ratio|Capitalization to Book Value Ratio PEN|Market Cap to Net Assets Ratio NOVT|HAE (Haemonetics Corp) - Market Cap to Book Value Multiple|Market Capitalization to Book Value Ratio INSP|PRCT (Procept) - Market Value to Book Value|Market Capitalization to Book Value Ratio PLSE (Pulse Biosciences, Inc.)|inmodemd.com (INMD) - Market-to-Book Ratio|PMI - Market Value to Book Value Ratio|Market Value to Book Value SRDX (Surmodics Inc)|SENS: Market Capitalization to Book Value Ratio|NeuroPace Medical (NPCE) - Market Capitalization to Book Value Ratio|Market Value to Book Value Ratio Tactile Systems Technology, Inc.|sanuwave.com - Market Capitalization to Net Assets|Market Capitalization to Book Value Ratio OM|ELMD - Market-to-Book Ratio|LENSAR, Inc - Market Cap to Net Assets Ratio|Market Capitalization to Book Value Ratio AVITA Medical Inc RCEL|PROF: Market Cap to Net Assets Ratio|Baird Medical Investment - Market Cap to Book Value Multiple|EDAP: Market Capitalization to Book Value Ratio|APYX - Market Capitalization to Book Value|ICCM (IceCure Medical Ltd.) - Market Capitalization to Book Value Ratio|Market Cap to Net Assets Ratio Pulmonx Corp. (LUNG)|Market Cap to Net Assets Ratio TELA (TELA Bio, Inc.)|CTSO (cytosorbents.com) - Market Value to Book Value|Market Value to Book Value Ratio Sensus Healthcare SRTS|ZYXI - Market Cap to Net Assets Ratio|electroCore Medical - Market Capitalization to Book Value Ratio|Market-to-Book Ratio Vicarious Surgical Inc.|IINN: Market Capitalization to Book Value Ratio|Capitalization to Book Value Ratio ICU|IRIX (IRIDEX Corp) - Market Capitalization to Book Value Ratio|Intelligent Bio (INBS) - Market Capitalization to Book Value|Market Capitalization to Book Value Ratio XAIR|Market Cap to Net Assets Ratio Profusa, Inc PFSA|Market Capitalization to Book Value Ratio SSKN (STRATA Skin Sciences, Inc.)|Market Capitalization to Book Value Ratio GlucoTrack Inc. GCTK|NAOV - Market Value to Book Value Ratio|VERO: Market Value to Book Value Ratio|NUWE (CHF Solutions) - Market Cap to Net Assets Ratio|Aethlon Medical Corp - Market Value to Book Value|ASXC (Asensus Surgical Inc) - Market Capitalization to Book Value Ratio|Market-to-Book Ratio avinger.com AVGR|Market Value to Book Value Ratio biosig.com (BSGM)|Cutera Inc. (CUTR) - Market Value to Equity Ratio|Know Labs Corp - Market Cap to Net Assets Ratio|Market Capitalization to Book Value Ratio Inari Medical Corp NARI|Nevro Corp. - Market Capitalization to Book Value Ratio|Market Capitalization to Book Value ReShape Lifesciences RSLS|Silk Road Medical (SILK) - Market Value to Book Value Ratio